Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Qiming's Portfolio Company InventisBio Lists on STAR Market 2022-07-25 11:55
Qiming's Portfolio Company InventisBio Lists on STAR Market 2022-07-25 11:55
Qiming Venture Partners Announces Closing of Funds Totaling US$3.2 Billion 2022-07-11 09:00
Zai Lab Announces First Quarter 2022 Financial Results and Corporate Updates 2022-05-11 15:13
Qiming's Nisa Leung, Duane Kuang Named on 2022 Forbes Midas List 2022-04-13 09:20
Qiming's Portfolio Company Zai Lab Lists on Main Board of HKEX 2020-09-28 11:26
Zai Lab Announces Financial Results for Six Months Ended June 30, 2020 and Corporate Updates 2020-08-13 22:38
China NMPA Accepts NDA Submission of Ripretinib for Advanced Gastrointestinal Stromal Tumor 2020-07-20 22:39
Turning Point Therapeutics and Zai Lab Announce Exclusive License Agreement for Repotrectinib in Greater China 2020-07-08 11:37
Zai Lab Announces Positive Topline Results from the NORA Phase 3 Study of ZEJULA® as Maintenance Therapy for Chinese Patients with Platinum-sensitive, Recurrent Ovarian Cancer 2020-05-29 07:05
Zai Lab Announces First Chinese Patient Dosed in the Global Phase 3 ATTACK Trial of Sulbactam- Durlobactam for Patients with Carbapenem-Resistant Acinetobacter Infections 2020-05-19 09:45
Zai Lab Announces Financial Results for Full Year Ended December 31, 2019 and Corporate Updates 2020-03-20 00:21
1